Jennifer Laplante

1.1k total citations
15 papers, 517 citations indexed

About

Jennifer Laplante is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Jennifer Laplante has authored 15 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 6 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Jennifer Laplante's work include Influenza Virus Research Studies (14 papers), Respiratory viral infections research (11 papers) and Viral gastroenteritis research and epidemiology (3 papers). Jennifer Laplante is often cited by papers focused on Influenza Virus Research Studies (14 papers), Respiratory viral infections research (11 papers) and Viral gastroenteritis research and epidemiology (3 papers). Jennifer Laplante collaborates with scholars based in United States and Australia. Jennifer Laplante's co-authors include Kirsten St. George, Heather Hatch, Bryon E. Petersen, Si–Hyun Bae, Seh‐Hoon Oh, Matthew Shudt, David E. Wentworth, Steven A. Marshall, Larisa V. Gubareva and Joanne C. Porter and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Emerging infectious diseases.

In The Last Decade

Jennifer Laplante

15 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Laplante United States 10 249 197 172 94 91 15 517
Cathérine Costa France 15 260 1.0× 39 0.2× 171 1.0× 74 0.8× 70 0.8× 32 749
Helen Thornton United States 12 97 0.4× 74 0.4× 71 0.4× 153 1.6× 30 0.3× 23 396
Patricia Souza Brazil 12 100 0.4× 181 0.9× 254 1.5× 26 0.3× 15 0.2× 21 597
Geoff Culshaw United Kingdom 14 163 0.7× 41 0.2× 155 0.9× 51 0.5× 5 0.1× 39 635
Dănuţ Cimponeriu Romania 8 72 0.3× 31 0.2× 65 0.4× 125 1.3× 16 0.2× 27 359
Frédéric Reynier France 12 76 0.3× 55 0.3× 150 0.9× 84 0.9× 7 0.1× 15 430
Tanja Ruokoranta Finland 9 51 0.2× 127 0.6× 105 0.6× 283 3.0× 3 0.0× 16 472
Likuan Xiong China 12 96 0.4× 31 0.2× 84 0.5× 68 0.7× 19 0.2× 25 322
T. W. E. Robinson United Kingdom 15 228 0.9× 48 0.2× 44 0.3× 69 0.7× 19 0.2× 38 511
A Ohshima Japan 9 97 0.4× 70 0.4× 56 0.3× 56 0.6× 11 0.1× 14 356

Countries citing papers authored by Jennifer Laplante

Since Specialization
Citations

This map shows the geographic impact of Jennifer Laplante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Laplante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Laplante more than expected).

Fields of papers citing papers by Jennifer Laplante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Laplante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Laplante. The network helps show where Jennifer Laplante may publish in the future.

Co-authorship network of co-authors of Jennifer Laplante

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Laplante. A scholar is included among the top collaborators of Jennifer Laplante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Laplante. Jennifer Laplante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ramani, Rama, et al.. (2021). CACO-2 cells: A continuous cell line with sensitive and broad-spectrum utility for respiratory virus culture. Journal of Virological Methods. 293. 114120–114120. 5 indexed citations
2.
Mohan, Teena, Ha Nguyen, Krista Kniss, et al.. (2021). Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020. Emerging infectious diseases. 27(7). 1953–1957. 14 indexed citations
3.
Maćešić, Nenad, Jennifer Laplante, Justin G. Aaron, et al.. (2020). Baloxavir treatment of oseltamivir‐resistant influenza A/H1pdm09 in two immunocompromised patients. Transplant Infectious Disease. 23(3). e13542–e13542. 10 indexed citations
4.
Salvatore, Mirella, Jennifer Laplante, Rosemary Soave, et al.. (2020). Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir. Transplant Infectious Disease. 22(4). e13336–e13336. 10 indexed citations
5.
Kodiyanplakkal, Rosy Priya, Jennifer Laplante, Lars F. Westblade, et al.. (2019). Detection and Characterization of Influenza B Virus with Reduced Neuraminidase Susceptibility in a Stem Cell Transplant Recipient. Open Forum Infectious Diseases. 6(12). ofz493–ofz493. 2 indexed citations
6.
Spencer, Sarah, Ha Nguyen, Jennifer Laplante, et al.. (2018). 745. Surveillance for Oseltamivir-Resistant Influenza A(H1N1)pdm09 Virus Infections During 2016–2017 and 2017–2018, United States. Open Forum Infectious Diseases. 5(suppl_1). S267–S268. 2 indexed citations
7.
Mishin, Vasiliy P., Tatiana Baranovich, Rebecca Garten, et al.. (2016). A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants. Journal of Clinical Microbiology. 55(1). 145–154. 6 indexed citations
8.
Okomo‐Adhiambo, Margaret, Vasiliy P. Mishin, Katrina Sleeman, et al.. (2016). Standardizing the influenza neuraminidase inhibition assay among United States public health laboratories conducting virological surveillance. Antiviral Research. 128. 28–35. 12 indexed citations
9.
Laplante, Jennifer, et al.. (2016). Next generation sequencing for whole genome analysis and surveillance of influenza A viruses. Journal of Clinical Virology. 79. 44–50. 47 indexed citations
10.
Babady, N. Esther, Jennifer Laplante, Yi‐Wei Tang, & Kirsten St. George. (2015). Detection of a Transient R292K Mutation in Influenza A/H3N2 Viruses Shed for Several Weeks by an Immunocompromised Patient. Journal of Clinical Microbiology. 53(4). 1415–1418. 7 indexed citations
11.
Laplante, Jennifer & Kirsten St. George. (2014). Antiviral Resistance in Influenza Viruses. Clinics in Laboratory Medicine. 34(2). 387–408. 13 indexed citations
12.
Ghedin, Elodie, Jennifer Laplante, Jay V. DePasse, et al.. (2010). Deep Sequencing Reveals Mixed Infection with 2009 Pandemic Influenza A (H1N1) Virus Strains and the Emergence of Oseltamivir Resistance. The Journal of Infectious Diseases. 203(2). 168–174. 89 indexed citations
13.
Graitcer, Samuel B., Larisa V. Gubareva, Laurie Kamimoto, et al.. (2010). Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States. Emerging infectious diseases. 17(2). 255–257. 62 indexed citations
14.
Laplante, Jennifer, Steven A. Marshall, Matthew Shudt, et al.. (2009). Influenza Antiviral Resistance Testing in New York and Wisconsin, 2006 to 2008: Methodology and Surveillance Data. Journal of Clinical Microbiology. 47(5). 1372–1378. 20 indexed citations
15.
Oh, Seh‐Hoon, et al.. (2004). Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Laboratory Investigation. 84(5). 607–617. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026